Navigation Links
AuraSense Therapeutics Secures Series B Equity Investment
Date:12/22/2011

EVANSTON, Ill., Dec. 22, 2011 /PRNewswire/ -- AuraSense Therapeutics, a biopharmaceutical company commercializing spherical nucleic acid (SNA™) constructs as gene regulation- and chemo-therapeutics for a variety of diseases, including applications in oncology, dermatology, neurology, and for cardiovascular disorders, has closed its Series B financing.  Investors included Abbott Biotech Ventures, a subsidiary of Abbott.  Other key individual investors included Patrick Ryan, founder of Aon; David Walt, co-founder of Illumina; Eric Schmidt, Executive Chairman of Google; and Craig Mundie, Chief Research and Strategy Officer of Microsoft.  Terms of the investment were not disclosed.

"We are delighted to complete this financing and have this consortium of investors join us in our mission to transform the field of gene regulation," said Chad Mirkin, co-founder of AuraSense Therapeutics.  "This financing underscores the highly unique benefits of the SNA platform and will accelerate our efforts to develop it to its full potential – supporting therapies for multiple diseases."

Schiff Hardin LLP served as deal counsel to AuraSense Therapeutics for the investment transaction.

About AuraSense Therapeutics, LLC

AuraSense Therapeutics, LLC is a privately held biopharmaceutical company founded by Professors Chad A. Mirkin and C. Shad Thaxton at Northwestern University.  The Company is dedicated to developing and commercializing spherical nucleic acid (SNA™) conjugates.  Its proprietary SNA constructs possess unparalleled biocompatibility and versatility as therapeutics, and they hold great promise for combating the world's most threatening diseases.  The Company's SNA technology overcomes the most difficult obstacles to gene regulation:  genetic targeting with safe and effective in vivo performance.  For additional information about the company, please visit

SOURCE AuraSense Therapeutics, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
3. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
4. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
5. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
6. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
7. Protalix BioTherapeutics Treats First Patient in Phase III Clinical Trial of prGCD
8. TorreyPines Therapeutics Initiates a Phase I Multiple Dose Clinical Trial of Tezampanel
9. TorreyPines Therapeutics Completes Phase I Multiple Dose Clinical Trial of NGX267, a Selective M1 Agonist for the Potential Treatment of Cognitive Impairment Associated with Schizophrenia
10. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
11. Cell Therapeutics, Inc. (CTI) Sponsors Panel Discussion on Women and Lung Cancer on Capitol Hill
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... July 24, 2014  Alimera Sciences, Inc. (NASDAQ: ... in the research, development and commercialization of prescription ophthalmic ... quarter of fiscal year 2014 financial results after the ... conference call will follow on the same day at ... will be hosted by Dan Myers , President ...
(Date:7/24/2014)... 24, 2014  The American Association for Homecare ... mission to help address audit issues in the ... to be the information technology lead in shaping ... provider of billing and business management solutions for ... expertise to support this important initiative on behalf ...
(Date:7/24/2014)... July 24, 2014  In any given hospital in ... patients has at least one hospital-acquired infection, according to ... many of these infections prove fatal. And as increased ... number of patient deaths per year, infection control efforts ... Consequently, a stronger emphasis is being placed ...
Breaking Medicine Technology:Alimera Sciences To Release Second Quarter 2014 Results 2Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 2Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 3
... 11 In conjunction with its fourth quarter 2009 earnings release (expected ... (NYSE: CVD ) is pleased to invite you to listen ... the Internet on Thursday, January 28, 2010 at 9:00 a.m. ET. , ... and Slide Presentation, When: January 28, 2010, 9:00 ...
... 11 BD (Becton, Dickinson and Company) (NYSE: BDX ... its first fiscal quarter 2010 earnings conference call on Thursday, January ... press release detailing the quarter,s earnings earlier that morning. , The ... accessible through BD,s website at www.bd.com/investors and will be ...
Cached Medicine Technology:BD Announces Live Webcast of First Fiscal Quarter Earnings Conference Call 2
(Date:7/24/2014)... appears to increase the risk for head and neck cancer ... with DM, but the risk of HNC in patients with ... cancer is the sixth most common type of cancer. It ... an estimated 650,000 new cancer cases and 350,000 cancer deaths ... Insurance Research Database to examine the risk of HNC in ...
(Date:7/24/2014)... This year the Walk to End Alzheimer’s ... National Life, will be held on Saturday, September 20 in ... Fun Run at 7:50 am, the untimed 5k Run at ... “The Walk to End Alzheimer’s unites the entire community in ... against this devastating disease, “stated Linda Mitchell, CEO and president ...
(Date:7/24/2014)... two or more equally positive outcomes experience paradoxical ... activity in different regions of the brain, according ... research scholar at the Princeton Neuroscience Institute at ... people rated the desirability of more than 300 ... at images of paired products with different or ...
(Date:7/24/2014)... 24, 2014 Memantine was initially developed by ... in Germany under the brand name Akatinol; it was later ... Ebixa and in the USA to Forest Labs as Namenda. ... in 2013. In the US, Forest reported Namenda sales of ... in Canada, Australia and the European region has increased the ...
(Date:7/24/2014)... scientists at Carnegie Mellon University, working with high-throughput ... Berkeley National Laboratory, have devised a computational method ... normal breast cells turn malignant and as they ... for analyzing how genes interact with each other ... published today by the online journal PLOS ...
Breaking Medicine News(10 mins):Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 2Health News:Alzheimer's Association Walk to End Alzheimer's Steps Off Saturday, September 20 in Denver 3Health News:Brain's dynamic duel underlies win-win choices 2Health News:Brain's dynamic duel underlies win-win choices 3Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 2Health News:Memantine Discussed in New Comprehensive Patent Search Report by Ark Patent Intelligence Published at MarketPublishers.com 3Health News:Gene changes in breast cancer cells pinpointed with new computational method 2Health News:Gene changes in breast cancer cells pinpointed with new computational method 3
... people, mainly in developing countries, are disabled by infectious ... More than 12 million people in 88 countries are ... bite of infected sand flies. Nearly 2 million new ... the disease annually. , Researchers at the University ...
... Can a high-energy diet pill really save your job? ... manufacturers, clothing makers and other retailers are seeing a significant ... maker Zoller(R) Laboratories is reporting dramatically increased sales of ... , (Photo: http://www.newscom.com/cgi-bin/prnh/20081216/LA52707 ) , ...
... Targeting pigments in mucus could fight deadly,bacteria in lungs ... called phenazines that stain the mucus in the lungs ... spur dangerous infections, researchers say. , The pigments may ... into structured communities, according to a Massachusetts Institute of ...
... from and odds are that they know. Or maybe not. A new ... tools to scan the human genome must pay attention to ancestry when ... ... 2008 -- Ask someone where their ancestors were from and odds ...
... Institutes of Health (NIH) has awarded nearly $3 million to ... milk impacts the health outcomes and health care cost savings ... 1500 grams. , The grant will enable researchers at ... cohort of 600 very low birth weight infants born to ...
... there,s a scientific reason why older people tend to ... A University of Alberta medical researcher, in collaboration with ... older adults to remember fewer negative events than their ... than younger people when it comes to storing memory, ...
Cached Medicine News:Health News:UIC researchers hunting drugs for devastating parasitic disease 2Health News:Sales of Energy-Boosting Diet Pills Skyrocket as the Economy Falters 2Health News:Scientists Spot Key to Cystic Fibrosis Infections 2Health News:Genome-wide Association Studies Must Account for Ancestry 2Health News:Genome-wide Association Studies Must Account for Ancestry 3Health News:Study examines how breastfeeding impacts cost of care for very low birth weight infants 2Health News:Aging brains allow negative memories to fade 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: